RACHEL MORALES: Open Payments
NPI 1275121311 · FORT LAUDERDALE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$848 in 29 payments from 11 companies in 2025. Trend: 2023 $920 · 2024 $1,072 · 2025 $848
Food & beverage: $838Education: $10
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 3 | $323 |
| Madrigal Pharmaceuticals | 7 | $181 |
| ABBVIE INC. | 10 | $153 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| Ipsen Biopharmaceuticals, Inc | 1 | $34 |
| Celltrion USA Inc. | 1 | $26 |
| COLOPLAST CORP | 1 | $25 |
| Ardelyx, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Verona Pharma, Inc. | 1 | $15 |
Products named: VOQUEZNA, REZDIFFRA, LINZESS, RINVOQ, XIFAXAN, IQIRVO, MAVYRET, VEGZELMA.
Industry payments across FL — which companies pay providers there.
